RAC 1.78% $1.66 race oncology ltd

General Comments / Chat, page-7813

  1. 2,851 Posts.
    lightbulb Created with Sketch. 2902
    This could help the issue being PET scan not standard of care in Australia or US. The more likely scenario playing out is Cardio Protect gets breakthrough designation and is 1st pathway to approval. Then EMD AML to follow. They haven't kicked off EUR and 10 sites for a reason and i'm not convinced its all to do with EMA approval?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.